Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell
January 28, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
December 3, 2019
MedinCell receives $19 million grant for its mdc-WWM program
November 28, 2019
MedinCell to publish its activity report and financial information of the first half of 2019-2020 on December 3, 2019
November 19, 2019
MedinCell announces that mdc-CWM progresses as planned
September 25, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
September 10, 2019
